Astellas Pharma (OTCPK:ALPM.Y) 2026 R&D Day March 30, 2026 08:00 PM ET Company ParticipantsHidemaru Yamaguchi - Managing DirectorNaoki Okamura - President and CEONobuko Kato - Chief Communications and IR OfficerTadaaki Taniguchi - Chief Research and Development OfficerConference Call ParticipantsFumiyoshi Sakai - AnalystHiroyuki Matsubara - Equity Research AnalystMiki Sogi - VP and Senior Research AnalystNobuaki Sawada - AnalystSeiji Wakao - Senior AnalystShinichiro Muraoka - AnalystSteve Barker - Senior Eq ...

Biomea Fusion (NasdaqGS:BMEA) Fireside chat March 30, 2026 03:00 PM ET Company ParticipantsMick Hitchcock - Interim CEORamses Erdtmann - President and COOSteve Morris - Chief Development OfficerConference Call ParticipantsMichael King - Director of Research and Senior Biotechnology AnalystMichael KingWell, late addition, Mick Hitchcock, interim CEO. Ramses Erdtmann, Founder, Chief Operating Officer, and President. Finally, Steve Morris, who is the Chief Development Officer. I'm just gonna make a couple of o ...

Block (NYSE:SQ) Update / briefing March 30, 2026 01:00 PM ET Company ParticipantsBrad Axen - Tech Lead for Data and Machine LearningMatt Walsh - Host and ContributorMatt WalshGreat. Hi, everyone. Thank you all for coming or joining and listening in on On the Block number two. We had Jack Dorsey on a couple weeks ago, and I'm really excited to talk to Brad Axen. Brad is one of the small group of people who has built Goose and has built a lot of our AI tooling at Block that I know I've had a lot of conversati ...

Biomea Fusion (NasdaqGS:BMEA) Fireside chat March 30, 2026 01:00 PM ET Company ParticipantsMick Hitchcock - Interim CEO and DirectorRamses Erdtmann - Co-Founder, President, and COOThorsten Kirschberg - EVP of ChemistryConference Call ParticipantsAnupam Rama - Senior Biotech AnalystJoyce Zhou - Biotech Research AnalystModeratorAny recording may also be used in JPMorgan research. Participants are prohibited from posting, sharing, or distributing any part of this call or its content on social media platforms o ...

Connect Biopharma (NasdaqGM:CNTB) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsBarry Quart - CEO and DirectorDavid Szekeres - PresidentNat Charoensook - VP of Biotechnology Equity ResearchConference Call ParticipantsBrandon Folkes - Managing Director and Senior Healthcare AnalystJulian Harrison - Managing Director and Biotechnology AnalystThomas Flaten - Senior Research AnalystOperatorLadies and gentlemen, thank you for standing by, and welcome to the Connect Biopharma conference call. A ...

Viridian Therapeutics (NasdaqCM:VRDN) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsAlex Thompson - Research Managing Director of Biotech Equity ResearchFaisal Khurshid - Managing Director of Equity ResearchGavin Clark-Gartner - Managing Director of Biotechnology Equity ResearchGreg Rossino - Senior Director of Investor RelationsGregory Renza - Managing DirectorJason Butler - Managing DirectorLaura Chico - Managing DirectorLisa Walter - VPRadhika Tripuraneni - Chief Medical OfficerShan Wu ...

SEB (OTCPK:SVKE.F) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsPawel Wyszynski - Head of Investor RelationsConference Call ParticipantsNone - AnalystNone - AnalystNone - AnalystNone - AnalystNone - AnalystNone - AnalystPawel WyszynskiOkay, I believe we've reached some kind of critical mass, so I'll kick off. Welcome to SEB's Q1 2026 pre-close call. My name is Pawel Wyszynski, and I work in the Investor Relations team here at SEB. This call is being recorded. The script used will be publ ...

Alumis (NasdaqGS:ALMS) Update / briefing March 29, 2026 07:00 PM ET Company ParticipantsAlex Thompson - Managing Director of Biotechnology SectorAndrew Blauvelt - Dermatologist and Psoriasis ExpertChris Yu - VP of Biopharma Equity ResearchChristopher Raymond - Managing DirectorHao Shen - Biotech and Biopharma AssociateIris Gao - Equity Research Senior AssociateJohn Schroer - CFOJörn Drappa - Chief Medical OfficerKatie Degen - Equity Research AssociateMartin Babler - President and CEOConference Call Particip ...

Takeda Pharmaceutical Company (NYSE:TAK) Update / briefing March 28, 2026 08:30 PM ET Company ParticipantsChinwe Ukomadu - Head of Gastrointestinal and Inflammation Therapeutic Area UnitElizabeth Borgeson - Investor Relations OfficerHidemaru Yamaguchi - Managing DirectorHiroyuki Matsubara - Equity Research Senior AssociateJulie Kim - CEO-ElectRhonda Pacheco - President of U.S. Business UnitTony Ren - Head of Asia Healthcare ResearchConference Call ParticipantsSeiji Wakao - Executive Director and Senior Anal ...

Boston Scientific (NYSE:BSX) FY Conference March 28, 2026 06:30 PM ET Company ParticipantsBrad Sutton - Chief Medical Officer in AF SolutionsDavid Roman - Managing Director in Global Investment Research DivisionJosh Jennings - Managing DirectorKen Stein - Chief Medical OfficerLauren Tengler - VP of Investor RelationsMarty Leon - Study Co-Chair, Mallah Family Professor of Cardiology, and Chief Innovation OfficerMichael Jaff - Chief Medical Officer in Vascular TherapiesConference Call ParticipantsChris Pasqua ...